|
Volumn 33, Issue 5, 1992, Pages 652-658
|
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: Metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide
a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
OCTREOTIDE PENTETATE INDIUM IN 111;
OCTREOTIDE[3 TYROSINE];
PENTETREOTIDE;
RADIOPHARMACEUTICAL AGENT;
SOMATOSTATIN DERIVATIVE;
SOMATOSTATIN RECEPTOR;
UNCLASSIFIED DRUG;
ABDOMINAL SCINTISCANNING;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
DOSIMETRY;
DRUG METABOLISM;
ENDOCRINE TUMOR;
FEMALE;
GASTROINTESTINAL TUMOR;
HALF LIFE TIME;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY;
KIDNEY CLEARANCE;
LIVER;
MALE;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIOACTIVITY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SPLEEN;
TUMOR LOCALIZATION;
ADULT;
AGED;
COMPARATIVE STUDY;
FEMALE;
HUMAN;
INDIUM RADIOISOTOPES;
IODINE RADIOISOTOPES;
MALE;
MIDDLE AGE;
NEOPLASMS;
OCTREOTIDE;
PENTETIC ACID;
RADIATION DOSAGE;
RECEPTORS, NEUROTRANSMITTER;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
TISSUE DISTRIBUTION;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 0026720422
PISSN: 01615505
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (449)
|
References (0)
|